Sign Up to like & get
recommendations!
1
Published in 2018 at "Haematologica"
DOI: 10.3324/haematol.2017.185801
Abstract: Risk-stratification and treatment intensification according to minimal residual disease (MRD) analysis has improved outcomes of patients with acute lymphoblastic leukemia (ALL).[1][1],[2][2] However, a significant proportion of patients with T-cell ALL (T-ALL) still experience early relapse…
read more here.
Keywords:
impact absence;
lymphoblastic leukemia;
acute lymphoblastic;
patients cell ... See more keywords